Videos de Experimentos Relacionados

Examen físico para el examen físico.

Binu V John, Smitha Mary Thomas

Lancet (London, England)

|December 20, 2003

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Clinical Features and Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease With Increased Alcohol Intake.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Same author

Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.

Clinical and translational gastroenterology·2026

Same author

Hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD).

JHEP reports : innovation in hepatology·2026

Same author

AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.

Gastroenterology·2025

Same author

Reply: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD.

Hepatology (Baltimore, Md.)·2025

Same author

Reply: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

Hepatology (Baltimore, Md.)·2025

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

Examen físico para el examen físico.

Videos de Conceptos Relacionados

Artículos Relacionados

Clinical Features and Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease With Increased Alcohol Intake.

Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.

Hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD).

AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.

Reply: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD.

Reply: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Examen físico para el examen físico.

Videos de Conceptos Relacionados

Artículos Relacionados

Clinical Features and Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease With Increased Alcohol Intake.

Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.

Hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD).

AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.

Reply: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD.

Reply: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.